Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa
Loic Ysebaert,Francois Lemonnier,Gabriel Brisou,Olivier Casasnovas,Gian Matteo Pica,Emmanuel Bachy,Ludovic Fouillet,Julie Abraham,Stephanie Guidez,Marc Andre,Guillaume Cartron,Romain Guieze,Sylvain Carras,Benoit Tessoulin,Roch Houot,Bohrane Slama,Christophe Bonnet,Luc-Matthieu Fornecker,Marie-Helene Delfau,Clementine Sarkozy,Camille Laurent,Vincent Ribrag,Franck Morschhauser BLOOD(2023)
AI 理解论文
溯源树
样例